Cargando…

Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF

Background: Patients after undergoing ischemic stroke have a high risk of further cardiovascular disease (CVD) incidents. Monitoring risk factors is critical to prevent the recurrence of CVD. Objective: The aim of the study was to determine differences in the incidence of risk factors for CVD in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucki, Mateusz, Chlebuś, Ewa, Wareńczak, Agnieszka, Daroszewski, Przemysław, Lisiński, Przemysław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948762/
https://www.ncbi.nlm.nih.gov/pubmed/35329054
http://dx.doi.org/10.3390/ijerph19063368
_version_ 1784674731062984704
author Lucki, Mateusz
Chlebuś, Ewa
Wareńczak, Agnieszka
Daroszewski, Przemysław
Lisiński, Przemysław
author_facet Lucki, Mateusz
Chlebuś, Ewa
Wareńczak, Agnieszka
Daroszewski, Przemysław
Lisiński, Przemysław
author_sort Lucki, Mateusz
collection PubMed
description Background: Patients after undergoing ischemic stroke have a high risk of further cardiovascular disease (CVD) incidents. Monitoring risk factors is critical to prevent the recurrence of CVD. Objective: The aim of the study was to determine differences in the incidence of risk factors for CVD in a post-ischemic stroke patient group (SG) compared to the control group, which had not undergone ischemic stroke (CG), and to characterize them using the ICF (International Classification of Functioning, Disability and Health) classification system. Materials and Methods: The incidence of risk factors for recurrent CVD events were retrospectively analyzed in 55 patients in SG and 55 patients in CG. The results were translated into categories from the ICF classification system. Results: Atrial fibrillation (p = 0.013), carotid artery stenosis > 50% (p < 0.001), LDL > 71 mg/dL (p < 0.001), heart rate > 80/min (p = 0.007), taking NOAC (p = 0.008) and NSAIDs (p < 0.001) as well as nicotinism (p = 0.001) were significantly more common in SG compared to CG. The value of the distribution of the total incidence of CVD risk factors were observed to be higher for SG than for CG. In SG, both for males (p < 0.001) and females (p < 0.001) more risk factors for recurrent CVD incidents were observed compared to CG. Conclusions: Patients in SG differ in the occurrence of risk factors for CVD event compared to CG. The use of a single tool, such as the ICF assessment sheet, can be useful in assessing and analyzing risk factors for recurrent CVD events. This may help to reduce the risk of subsequent CVD events in secondary prevention.
format Online
Article
Text
id pubmed-8948762
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89487622022-03-26 Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF Lucki, Mateusz Chlebuś, Ewa Wareńczak, Agnieszka Daroszewski, Przemysław Lisiński, Przemysław Int J Environ Res Public Health Article Background: Patients after undergoing ischemic stroke have a high risk of further cardiovascular disease (CVD) incidents. Monitoring risk factors is critical to prevent the recurrence of CVD. Objective: The aim of the study was to determine differences in the incidence of risk factors for CVD in a post-ischemic stroke patient group (SG) compared to the control group, which had not undergone ischemic stroke (CG), and to characterize them using the ICF (International Classification of Functioning, Disability and Health) classification system. Materials and Methods: The incidence of risk factors for recurrent CVD events were retrospectively analyzed in 55 patients in SG and 55 patients in CG. The results were translated into categories from the ICF classification system. Results: Atrial fibrillation (p = 0.013), carotid artery stenosis > 50% (p < 0.001), LDL > 71 mg/dL (p < 0.001), heart rate > 80/min (p = 0.007), taking NOAC (p = 0.008) and NSAIDs (p < 0.001) as well as nicotinism (p = 0.001) were significantly more common in SG compared to CG. The value of the distribution of the total incidence of CVD risk factors were observed to be higher for SG than for CG. In SG, both for males (p < 0.001) and females (p < 0.001) more risk factors for recurrent CVD incidents were observed compared to CG. Conclusions: Patients in SG differ in the occurrence of risk factors for CVD event compared to CG. The use of a single tool, such as the ICF assessment sheet, can be useful in assessing and analyzing risk factors for recurrent CVD events. This may help to reduce the risk of subsequent CVD events in secondary prevention. MDPI 2022-03-12 /pmc/articles/PMC8948762/ /pubmed/35329054 http://dx.doi.org/10.3390/ijerph19063368 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lucki, Mateusz
Chlebuś, Ewa
Wareńczak, Agnieszka
Daroszewski, Przemysław
Lisiński, Przemysław
Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF
title Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF
title_full Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF
title_fullStr Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF
title_full_unstemmed Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF
title_short Assessment of CVD Risk Factors in Secondary Prevention after Ischemic Stroke Using the ICF
title_sort assessment of cvd risk factors in secondary prevention after ischemic stroke using the icf
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948762/
https://www.ncbi.nlm.nih.gov/pubmed/35329054
http://dx.doi.org/10.3390/ijerph19063368
work_keys_str_mv AT luckimateusz assessmentofcvdriskfactorsinsecondarypreventionafterischemicstrokeusingtheicf
AT chlebusewa assessmentofcvdriskfactorsinsecondarypreventionafterischemicstrokeusingtheicf
AT warenczakagnieszka assessmentofcvdriskfactorsinsecondarypreventionafterischemicstrokeusingtheicf
AT daroszewskiprzemysław assessmentofcvdriskfactorsinsecondarypreventionafterischemicstrokeusingtheicf
AT lisinskiprzemysław assessmentofcvdriskfactorsinsecondarypreventionafterischemicstrokeusingtheicf